Annual report pursuant to Section 13 and 15(d)

Accounts Receivable and Concentration of Credit Risk (Narrative) (Details)

v3.10.0.1
Accounts Receivable and Concentration of Credit Risk (Narrative) (Details)
12 Months Ended
Dec. 27, 2017
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
customer
Sep. 30, 2017
USD ($)
customer
Feb. 28, 2018
USD ($)
Long term trade receivable       $ 7,837,500  
Accounts receivable     $ 3,972,632 11,256,238  
Current accounts receivable, net     3,972,632 3,418,738  
Current liability     3,226,036 2,685,718  
Net revenues     $ 15,864,483 $ 13,655,592  
Accounts Receivable [Member]          
Concentration risk, percentage     74.00%    
Number of Customers | customer     3    
Total Revenue [Member]          
Number of Customers | customer     3 2  
Semina [Member]          
Payments to settle agreement $ 2,200,000     $ 1,300,000  
Long term trade receivable $ 7,500,000     7,800,000  
Accounts receivable       8,900,000  
Current accounts receivable, net       1,100,000 $ 1,500,000
Payables       1,400,000  
Long term liability       1,200,000  
Current liability       $ 200,000  
Settlement loss on receivables     $ 4,000,000    
Semina [Member] | Assets, Current [Member]          
Concentration risk, percentage       11.00%  
Semina [Member] | Accounts Receivable And Long-Term Other Receivables [Member]          
Concentration risk, percentage       79.00%  
USAID [Member]          
Net revenues     $ 3,000,000 $ 5,800,000  
USAID [Member] | Assets, Current [Member]          
Concentration risk, percentage     15.00%    
UNFPA [Member]          
Net revenues     $ 4,100,000 $ 3,300,000  
Barrs Medical (PTY) Ltd [Member]          
Net revenues   $ 2,900,000